Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 3, 1999, Pages 589-595

  MacKenzie, Robert ^a   Balogh, Judith ^a   Choo, Richard ^a   Franssen, Edmee ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Accelerated fractionation; Concomitant boost; Head and neck; Radiotherapy; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; DERMATITIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; MUCOSA INFLAMMATION; PHARYNGITIS; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA;

EID: 0032823423     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00218-7     Document Type: Article

References (39)

1. Wang C.C. Radiation therapy for head and neck neoplasms Indications, techniques and results . 1983;Wright-PSG Inc, Littleton, MA.
2. Fletcher GH. Textbook of radiotherapy. Philadelphia; 1980.
3. Garrett P.G., Beale F.A., Cummings B.J., et al. Carcinoma of the tonsil The effect of dose-time-volume factors on local control . Int J Radiat Oncol Biol Phys. 11:1985;703-706.
4. Perez C.A., Purdy J.A., Breaux S.R., et al. Carcinoma of the tonsillar fossa A nonrandomized comparison of preoperative radiation and surgery or irradiation alone: Long term results . Cancer. 50:1982;2314-2322.
5. Weller S.A., Goffinet D.R., Goode R.L., et al. Carcinoma of the oropharynx Results of megavoltage radiation therapy in 305 patients . Am J Roentgenol. 126:1976;236-247.
6. Thames H.D., Peters L.J., Spanos W. Dose response of squamous cell carcinomas of the upper respiratory and digestive tracts. Br J Cancer. 41:(Suppl. 4):1980;35.
7. Marcial V.A., Hanley J.A., Hendrickson F., et al. Spit-course radiation therapy of carcinoma of the base of the tongue Results of a prospective national collaborative clinical trial conducted by the Radiation Therapy Oncology Group . Int J Radiat Oncol Biol Phys. 9:1983;437-443.
8. Keane T.J., Hawkins N.V., Beale F.A., et al. Carcinoma of the hypopharynx Results of primary radical radiation therapy . Int J Radiat Oncol Biol Phys. 9:1983;659-664.
9. Stewart J.G., Jackson A.W. The steepness of the dose response curve both for tumor cure and normal tissue injury. Laryngoscope. 7:1975;1107.
10. Harwood A.R. Cancer of the larynx - the Toronto experience. J Otolaryngol. 11:(Suppl.):1982;1-21.
11. Ghossein N.A., Bataini J.P., Ennuyer A., et al. Local control and site of failure in radically irradiated supraglottic laryngeal cancer. Radiology. 112:1974;187-192.
12. Fu K.K., Eisenberg L., Dedo H.H., et al. Results of integrated management of supraglottic carcinoma. Cancer. 40:1977;2874-2881.
13. Harwood A.R., Hawkins N.V., Beale F.A., et al. Management of advanced glottic cancer A 10 year review of the Toronto experience . Int J Radiat Oncol Biol Phys. 5:1979;899-904.
14. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
15. Datta N.R., Choudhry A.D., Gupta S. Twice a day versus once a day radiation therapy in head and neck cancer. (Abstr.) Int J Radiat Oncol Biol Phys. 17:1989;132.
16. Overgaard J., Sand Hansen H., Sapru W., et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck: A randomized multicentre study of 5 versus 6 fractions per week - preliminary report from DAHANCA 6 and 7 trial. (Abstr) Radiother Oncol. 40:(Suppl. 1):1996;S31.
17. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improved head and neck cancers Results of the EORTC 22851 randomized trial . Radiother Oncol. 44:1997;111-121.
18. Pinto L., Canary P., Araujo C., et al. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages II and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 21:1991;557-562.
19. Withers H.R., Taylor J.M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica. 27:1988;131-146.
20. Fowler J.F., Lindstrom M.J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 23:1992;457-467.
21. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 19:1990;1339-1345.
22. TNM classification of malignant tumours. 1992;Springer-Verlag, Berlin.
23. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
24. SAS/STAT User's Guide. Cary, NC: SAS Institute Inc.; 1989.
25. Jackson S.M., Weir L.M., Hay J.H., et al. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 43:1997;39-46.
26. Maciejewski B., Skladowski K., Pilecki B., et al. Randomized clinical trial of accelerated 7 days per week fractionation in radiotherapy for head and neck cancer Preliminary report on acute toxicity . Radiother Oncol. 40:1996;137-145.
27. Dische S., Saunders M.A.B. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
28. Awwad H.K., Khafaagy Y., Barsoum M. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer Influence of tumour proliferation . Radiother Oncol. 25:1992;261-266.
29. Ang KK, Trotti A, Garden AS; et al. Importance of overall time factor in postoperative radiotherapy. Proceedings of the 4th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 1996;1:231-235.
30. Knee R., Fields R.S., Peters L.J. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 4:1985;1-7.
31. Harrison L.B., Pfister D.G., Fass D.E., et al. Concomitant chemotherapy-radiation therapy followed by hyperfractioned radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys. 21:1991;703-708.
32. Kaanders J.H., van Daal W.A., Hoogenraad W.J., et al. Accelerated fractionaton radiotherapy for laryngeal cancer, acute and late toxicity. Int J Radiat Oncol Biol Phys. 24:1992;497-503.
33. Schmidt-Ullrich R.K., Johnson C.R., Wazer D.E., et al. Accelerated superfractionated irradiation for advanced carcinoma of the head and neck Concomittant boost technique . Int J Radiat Oncol Biol Phys. 21:1991;563-568.
34. Trotti A., Klotch D., Endicott J., et al. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck Long-term results of a prospective trial . Head Neck. 20:1998;119-123.
35. Kaanders J.H., Pop L.A.M., Marres H.A.M., et al. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol. 48:1998;115-122.
36. Cox J.D., Pajak T.F., Marcial V.A., et al. Astro plenary Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group protocol 8313 . Int J Radiat Oncol Biol Phys. 20:1991;1191-1195.
37. Munro A.J. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer. 71:1995;83-91.
38. El-Sayed S., Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region A meta-analysis of prospective and randomized trials . J Clin Oncol. 14:1996;838-847.
39. Harari P.M. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol. 15:1997;2050-2055.